Abstract

Doc number: 283

Abstract

Background: Several different strategies have been reported for the treatment of chondromyxoid fibromas, all with variable outcomes and high recurrence rates.

Methods: We report on 22 consecutive cases of chondromyxoid fibromas treated by intralesional curettage, four of which had adjuvant cementation at our institution between 2003 and 2010. We assessed the functional outcome using the Musculoskeletal Tumour Society (MSTS) scoring system.

Results: Nine males and 16 females with a mean age of 36.5 years (range 11 to 73) and a mean follow-up of 60.7 months were included in the study. Local recurrence occurred in two patients (9%) within the first 2 years following the index procedure. This was treated by re-curettage only of the residual defect. Two postoperative complications occurred: a superficial wound infection in one patient and a transient deep peroneal nerve neurapraxia in the other. The mean postoperative MSTS score was 96.7%.

Conclusions: Intralesional curettage and cementation is as an effective treatment strategy for chondromyxoid fibromas, providing satisfactory functional results with a low recurrence rate. Careful case selection with stringent clinical and radiographic follow-up is recommended.

Details

Title
Chondromyxoid fibroma management: a single institution experience of 22 cases
Author
Bhamra, Jagmeet S; Al-Khateeb, Hesham; Dhinsa, Baljinder S; Gikas, Panos D; Tirabosco, Roberto; Pollock, Robin C; Skinner, John A; Aston, William J; Saifuddin, Asif; Briggs, Timothy WR
Publication year
2014
Publication date
2014
Publisher
BioMed Central
e-ISSN
14777819
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1609395066
Copyright
© 2014 Bhamra et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.